Pfizer to supply global fund up to 6 million PAXLOVID treatment courses for low-and-middle-income countries
On Supt. 22, 2022, Pfizer announced an agreement to supply up to six million treatment courses of its…
On Supt. 22, 2022, Pfizer announced an agreement to supply up to six million treatment courses of its…
On Supt. 22, 2022, with a five-year, $126 million grant from the National Institutes of Health (NIH), a…
On Sept. 21, 2022, the AACR released the 12th edition of its AACR Cancer Progress Report, an annual…
On Sept. 20, 2022, The health authorities in Uganda declared an outbreak of Ebola after a case of…
On Sept. 20, 2022, the University of California, Davis announced that the amphibian decline in Latin America in…
On Sept. 17, 2022, the Democratic Republic of the Congo declared the end of an Ebola outbreak that…
On Sept. 16, 2022, Novavax announced that the Taiwan Food and Drug Administration had granted expanded emergency use…
On Sept. 16, 2022, Novavax announced that the Israel Ministry of Health had granted an import and use…
On Sept. 15, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On Sept. 15, 2022, Gilead Sciences announced updates to the World Health Organizationメs Therapeutics and COVID-19: living guideline,…
On Sept. 15, 2022, the National Institutes of Health announced that a research team funded by the NIH…
On Sept. 14, 2022, The U.S. Biotech Initiative was announced detailing new investments and resources to advance the…
On Sept. 13, 2022, Novavax and Serum Institute of India, the world’s largest vaccine manufacturer by volume, announced…
On Sept. 13, 2022, the National Institutes of Health announced it will invest $130 million over four years,…
On Sept. 12, 2022, the White House announced an executive order to advance biotechnology and biomanufacturing towards innovative…
On Sept. 8, 2022, the U.S. Department of Agricultureメs Animal and Plant Health Inspection Service launched an updated…
On Sept. 8, 2022, a clinical trial evaluating alternative strategies for administering the JYNNEOS mpox vaccine to increase…
On Sept. 8, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced that Stuart and Molly Sloan had pledged…
On Sept. 8, 2022, researchers from the University of Oxford and their partners reported findings from their Phase…
On Sept. 7, 2022, the U.S. Food and Drug Administration (FDA) announced it had approved Revance Therapeutics’ DAXXIFY…
On Sept. 7, 2022, Quest Diagnostics announced that it had received emergency use authorization (EUA) from the U.S….
On Sept. 6, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service had reviewed…
On Sept. 6, 2022, scientists in China announced that they had conducted the first comprehensive study of the…
On Sept. 2, 2022, Novavax announced that Swissmedic, the Swiss Agency for Therapeutic Products, had expanded its temporary…
On Sept. 2, 2022, Novavax announced that the World Health Organization (WHO) had approved a variation to allow…
On Sept. 1, 2022, Novavax announced that Nuvaxovid (NVX-CoV2373) COVID-19 vaccine had been recommended for expanded conditional marketing…
On Aug. 31, 2022, a new front-door to the University of Victoria opened to advance health and life…
On Aug. 31, 2022, the Yale New Haven Hospital broke ground on the $838 million, 505,000 square foot…
On Aug. 29, 2022, the U.S. Department of Health and Human Services (HHS) announced it had provided approximately…
On Aug. 29, 2022, a group of international researchers, coordinated by Dr Jo�o Teixeira at The Australian National…